Gabriele Allegri has joined Diasorin as 𝗣𝗿𝗲𝘀𝗶𝗱𝗲𝗻𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗜𝗺𝗺𝘂𝗻𝗼 𝗗𝗶𝘃𝗶𝘀𝗶𝗼𝗻, bringing a distinguished global career that spans leadership roles at Johnson & Johnson, Accenture, and the Precision Cancer Consortium. He is widely recognized for his expertise in precision medicine, companion diagnostics, and healthcare commercialization.
In his new role, Gabriele will lead DiaSorin’s efforts to accelerate advancements in specialty testing and immunodiagnostics. His background in market access and transformational healthcare strategies will be pivotal in strengthening the company’s position as a global specialist in life sciences and diagnostics.
Share your Details for subscribe